Silent,
Just to clarify Neuren received Orphan Drug status but was denied Breakthrough therapy designation by the FDA. From my very limited knowledge these are two very different FDA approvals.
Ann: Annual Report to shareholders, page-18
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$23.11 |
Change
-0.860(3.59%) |
Mkt cap ! $2.951B | |||
| Open | High | Low | Value | Volume |
| $23.93 | $23.97 | $23.05 | $23.02M | 985.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 5083 | $23.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $23.25 | 1026 | 2 |
View Market Depth
| Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$23.22 |
Change
-0.860 ( 3.12 %) |
||||
| Open | High | Low | Volume | ||
| $23.81 | $23.94 | $23.05 | 198298 | ||
| Last updated 15.59pm 28/05/2024 ? | |||||
| NEU (ASX) Chart |